Bao P, Wu C, Gu K, Gong Y, Peng P, Huang Z, Zhang M, Zheng Y, Zhong W (2016) Incidence trend of malignant tumors in children in Shanghai. Chin J Epidemiol 37(1):106–110. https://doi.org/10.3760/cma.j.issn.0254-6450.2016.01.023

Article  Google Scholar 

Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A, BFM Group (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 131(1):39–49. https://doi.org/10.1111/j.1365-2141.2005.05735.x

Article  PubMed  Google Scholar 

Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, Weston C, Perkins SL, Raphael M, McCarthy K, Patte C, FAB LMB96 International Study Committee (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 109(7):2736–2743. https://doi.org/10.1182/blood-2006-07-036665

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL (2004) Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 28(4):464–470. https://doi.org/10.1097/00000478-200404000-00005

Article  PubMed  Google Scholar 

Coiffier B (2007) Rituximab therapy in malignant lymphoma. Oncogene 26(25):3603–3613. https://doi.org/10.1038/sj.onc.1210376

Article  CAS  PubMed  Google Scholar 

Colomo L, López-Guillermo A, Perales M, Rives S, Martínez A, Bosch F, Colomer D, Falini B, Montserrat E, Campo E (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood101(1):78–84. https://doi.org/10.1182/blood-2002-04-1286

Article  CAS  Google Scholar 

Fu Y, Wang H, Zhai X, Qian X, Meng J, Miao H, Zhu X, Yu Y, Lu F (2019) Improved outcome of newly diagnosed childhood mature B-Cell lymphoma/leukemia with high tumor burden treated with BFM95-based protocol combining rituximab: A report from shanghai, China. J Pediatr Hematol Oncol 41(3):170–174. https://doi.org/10.1097/MPH.0000000000001419

Article  CAS  PubMed  Google Scholar 

Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275–282. https://doi.org/10.1182/blood-2003-05-1545

Article  CAS  PubMed  Google Scholar 

Iqbal J, Liu Z, Deffenbacher K, Chan WC (2009) Gene expression profiling in lymphoma diagnosis and management. Best Pract Res Clin Haematol 22(2):191–210. https://doi.org/10.1016/j.beha.2009.05.001

Article  CAS  PubMed  Google Scholar 

Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan WC (2011) BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clin Cancer Res 17(24):7785–7795. https://doi.org/10.1158/1078-0432.CCR-11-0267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SB (1990) Results of treatment of childhood localized non-Hodgkin’s lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 322(17):1169–1174. https://doi.org/10.1056/NEJM199004263221701

Article  CAS  PubMed  Google Scholar 

Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG, European Intergroup for Childhood Non-Hodgkin Lymphoma, Children’s Oncology Group (2020) Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children. N Engl J Med 382(23):2207–2219. https://doi.org/10.1056/NEJMoa1915315

Article  Google Scholar 

Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker HH, Burkhardt B, Harder L, Siebert R, Reiter A, Parwaresch R (2006) Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) multicenter trial. Blood 107(10):4047–4052. https://doi.org/10.1182/blood-2005-10-4213

Article  CAS  PubMed  Google Scholar 

Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphaël M, Terrier-Lacombe MJ Société Française d’Oncologie Pédiatrique (2001) The Société Française d’Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97(11):3370–3379. https://doi.org/10.1182/blood.v97.11.3370

Article  Google Scholar 

Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, Weston C, Raphael M, Perkins SL, McCarthy K, Cairo MS, FAB/LMB96 International Study Committee (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109(7):2773–2780. https://doi.org/10.1182/blood-2006-07-036673

Article  CAS  PubMed  PubMed Central  Google Scholar 

PDQ Pediatric Treatment Editorial Board (2024) Childhood Non-Hodgkin Lymphoma Treatment (PDQ®): Health Professional Version. 2024 Nov 27. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65738. Accessed 24 December 2024

Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Müller-Weihrich S, Plüss HJ, Zintl F, Henze G, Riehm H (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster group trial NHL-BFM 90. Blood 94(10):3294–3306. https://doi.org/10.1182/blood.V94.10.3294.422k12_3294_3306

Article  CAS  PubMed  Google Scholar 

Reiter A, Klapper W (2008) Recent advances in the Understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol 142(3):329–347. https://doi.org/10.1111/j.1365-2141.2008.06988.x

Article  CAS  PubMed  Google Scholar 

Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937–1947. https://doi.org/10.1056/NEJMoa012914

Article  PubMed  Google Scholar 

Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS (2015) Revised international pediatric Non-Hodgkin lymphoma staging system. J Clin Oncol 33(18):2112–2118. https://doi.org/10.1200/JCO.2014.59.7203

Article  PubMed  PubMed Central  Google Scholar 

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (2017) Word Health Organization classification of tumor of hematopoietic and lymphoid tissue. Revised 4th Edition. Lyon: Int Agency Res Cancer; 2017:216–344

Article  Google Scholar 

Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Juergens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A, BFM Group (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM group study NHL-BFM95. Blood 105(3):948–958. https://doi.org/10.1182/blood-2004-03-0973

Article  CAS  PubMed  Google Scholar 

Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE, Christian B, DeVos S, Dholaria B, Fayad LE, Habermann TM, Hamid MS, Hernandez-Ilizaliturri F, Hu B, Kaminski MS, Karimi Y, Kelsey CR, King R, Krivacic S, LaCasce AS, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2023) NCCN Guidelines® insights: B-Cell lymphomas, version 6.2023. J Natl Compr Canc Netw 21(11):1118–1131. https://doi.org/10.6004/jnccn.2023.0057

Article  CAS  PubMed  Google Scholar